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ties because this ultimately improves the quality of patient care.
And that, or course, is the goal that all medical and surgical
specialties and subspecialties ultimately share.
Mitchel P. Goldman, MD
Robert A. Weiss, MD
University of California, San Diego
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Regarding “Ultrasound findings after radiofrequency
ablation of the great saphenous vein:
Descriptive analysis”
The letter by renowned dermatologic specialists, Mitchel P.
Goldman, MD, and Robert A. Weiss, MD, touches on the follow-
ing topics of importance: (1) tumescent anesthesia; (2) experience
with endovascular treatment of the saphenous vein, including
radiofrequency ablation (RFA); (3) regular post-treatment fol-
low-up with duplex ultrasound evaluation; (4) complete lack of
small vessel network; (5) why ligation may decrease inflammation
and, by association, small vessel networks; and (6) concerns ex-
pressed regarding lack of reference to their work.
Our short responses to these items are as follows:
Regarding 1 and 2, the Jobst Vascular Center experience with
tumescent anesthesia and RFA parallels theirs in large number,
excellent results, and patient satisfaction. Tumescent anesthesia has
been a fundamental component of the RFA procedure; however, it
is not central to the issues addressed by this study.
Regarding 3 and 4, regular post-treatment ultrasound fol-
low-up with standard venous settings often fails to detect small
arteries and veins. Increased sensitivity is needed. For example, all
patients with telangiectasias have small vessel networks. A signifi-
cant proportion of patients treated for saphenous vein insufficiency
have telangiectasias. Most of these patients continue to have small
vessel networks after RFA. However, to detect these small vessels
with low flow volume and low velocities, special ultrasound set-
tings must be used to increase color-flow sensitivity. For this study,
flow sensitivity was increased twofold by decreasing the velocity
scale as affected by pulse repetition frequency. Moreover, color
gain was maintained just below noise levels to ensure maximal
sensitivity. These techniques, combined with avoidance of probe
compression, are essential to follow-up testing.
Regarding 5, inflammation may occur or reoccur long after
the effects of tumescent anesthesia have disappeared. One possible
explanation is the process of thrombosis-recanalization—throm-
bosis that occurs in untreated vein segments adjacent to the treated
saphenous vein as well as the treated vein itself. For example, large
vein valve sinuses may not degenerate and may respond differently
than intervalve segments with smaller diameters. Vein valve sinuses
connected to small tributaries have been a preferred location for
thrombosis and small segment recanalization.
It may be that ligation at the saphenofemoral junction de-
creases the number of normal vessels. It also decreases the potential
for thrombosis-recanalization of the proximal segment of the great
saphenous vein. Without ligation, thrombus may extend beyond
the initiation of RFA, stimulating an inflammatory reaction that
then stimulates the development of small arteries and veins.
Regarding 6, we regret our oversight in not including at least
1 of the 5 references of their work. In our behalf, however, we
would like to mention that references 1 and 2 of their letter were
cited in our previous publication describing the fate of the great
saphenous vein after RFA (Vasc Endovasc Surg 2004;38:339-
344). References 3 and 4 focused specifically on tumescent anes-
thesia, which wasn’t the point of our paper, and reference 7 was too
recent to be cited. Given the limit of references properly imposed
by the editors, we believe that the references selected for this paper
are appropriate.
We also support efforts to share information across specialties
and endorse their reasons. We hope that both their comments and
our reply contribute to this objective.
Sergio X. Salles-Cunha, PhD
Jobst Vascular Center
Toledo, Ohio
doi:10.1016/j.jvs.2005.02.014
Regarding “Deep vein thrombosis after
radiofrequency ablation of greater saphenous vein: A
word of caution”
We read this excellent article (J Vasc Surg 2004;40:500-4)
with interest. We agree with the authors that several factors are
involved in luminal obliteration and that a postoperative duplex
scan is mandatory in the first week after ablation to check for deep
vein thrombosis (DVT) and flow in the deep veins and greater
saphenous vein (GSV). We also agree that the reporting of adverse
events should be unbiased and above commercial interests. The
authors report a 16% incidence of early DVT. This is in contrast to
our results.
Our experience with radiofrequency ablation (RFA) extends
over a 5-year period and consists of 90 patients (26 men, 64
women) with a mean age of 45 years (range, 15 to 80). Most were
CEAP class 2 to 4. All cases were performed under general anaes-
thesia, and patients underwent stab avulsions after ablation. Our
operating equipment was similar to that of the authors. All of our
patients had at least one duplex scan during the first week, per-
formed by experienced personnel who followed a strict protocol.
None of our patients developed early DVT. Our 67th patient had
a thrombus situated at the saphenofemoral junction, with normal
flow and no thrombus in the femoral vein, and was anticoagulated
for 3 months.
Our method differs from the authors’ in the following re-
spects:
1. No routine preoperative screening for hypercoagulability
was done unless indicated.1
2. All patients received a single, subcutaneous dose of prophy-
lactic tinzaparin sodium (3,500 U) immediately before sur-
gery.
3. A guidewire was not used routinely for placement of the
ablation catheter.
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